TickerFacts.

Structure Therapeutics Inc. (GPCR): Shareholders' Equity

Annual figures by period end, from SEC filings.

$1.52B
As of 2025-12-31
$1.35B
As of 2026-06-30
2022-12-31: -$115.14M2023-12-31: $452.97M2024-12-31: $864.84M2025-12-31: $1.52B$1.52B
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$1.52B+75.3%2026-02-26, Balance as of period end
2024-12-31$864.84M+90.9%2026-02-26, Balance as of period end
2023-12-31$452.97Mn/m2026-02-26, Balance as of period end
2022-12-31-$115.14Mn/a2024-03-08, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Structure Therapeutics Inc. (GPCR)2025-12-31$1.52B+75.3%
Acadia Pharmaceuticals Inc (ACAD)2025-12-31$1.23B+67.5%
Ligand Pharmaceuticals Inc (LGND)2025-12-31$1.02B+22.5%
Amphastar Pharmaceuticals, Inc. (AMPH)2025-12-31$788.80M+7.7%
Innoviva, Inc. (INVA)2025-12-31$1.17B+69.7%
Ultragenyx Pharmaceutical Inc. (RARE)2025-12-31-$80.00Mn/m
Collegium Pharmaceutical, Inc (COLL)2025-12-31$301.68M+31.8%
Phibro Animal Health Corp (PAHC)2026-06-30$385.48M+34.9%
Supernus Pharmaceuticals, Inc. (SUPN)2025-12-31$1.06B+2.5%

Compare GPCR, ACAD, LGND, AMPH side by side · Screen every company in Pharmaceutical Preparations ↗